Axa’s LivePerson LPSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,074
Closed -$4.86M 1217
2021
Q4
$4.86M Hold
9,074
0.01% 670
2021
Q3
$8.02M Hold
9,074
0.02% 559
2021
Q2
$8.61M Hold
9,074
0.02% 556
2021
Q1
$7.18M Hold
9,074
0.02% 606
2020
Q4
$8.47M Hold
9,074
0.03% 560
2020
Q3
$7.08M Buy
9,074
+2,055
+29% +$1.54M 0.03% 543
2020
Q2
$4.36M Sell
7,019
-694
-9% -$323K 0.02% 658
2020
Q1
$2.63M Buy
7,713
+713
+10% +$346K 0.01% 678
2019
Q4
$3.88M Buy
+7,000
New +$4.02M 0.02% 682

Other funds holding LPSN

Axa's LPSN Position: Q1 2022 in Review

Axa sold out of LivePerson (LPSN) in Q1 2022, closing a stake of 9,074 shares — an estimated $4.86M sold.

Axa first reported a position in LPSN in Q4 2019 and held it in 9 quarters. The position peaked at $8.61M in Q2 2021. 212 funds tracked by Wall St. Rank hold LPSN as of Q1 2022.

  • Axa reported no remaining LivePerson position as of Q1 2022 after selling out during the quarter.
  • Axa sold 9,074 LivePerson shares in Q1 2022, an estimated $4.86M.
  • Axa first reported a position in LivePerson in Q4 2019 and held it in 9 quarters.
  • Axa's LivePerson position peaked at $8.61M in Q2 2021.
  • 212 funds tracked by Wall St. Rank held LivePerson as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.